
1. j natl cancer inst. 2015 dec 27;108(2). pii: djv390. doi: 10.1093/jnci/djv390.
print 2016 feb.

response.

wentzensen n(1), fetterman b(2), castle p(2), schiffman m(2), wood s(2), tokugawa
d(2), bodelon c(2), poitras n(2), lorey t(2), kinney w(2).

author information: 
(1)division cancer epidemiology genetics, national cancer institute,
national institutes health, rockville, md (nw, ms, sw, cb); kaiser permanente 
tpmg regional laboratory, berkeley, ca (bf, dt, np, tl); global coalition against
cervical cancer, arlington, va (pc); albert einstein college medicine, bronx, 
ny (pc); division gynecologic oncology, kaiser permanente medical care
program, oakland, ca (wk). wentzenn@mail.nih.gov.
(2)division cancer epidemiology genetics, national cancer institute,
national institutes health, rockville, md (nw, ms, sw, cb); kaiser permanente 
tpmg regional laboratory, berkeley, ca (bf, dt, np, tl); global coalition against
cervical cancer, arlington, va (pc); albert einstein college medicine, bronx, 
ny (pc); division gynecologic oncology, kaiser permanente medical care
program, oakland, ca (wk).

comment on
    j natl cancer inst. 2016 feb;108(2). pii: djv389. doi: 10.1093/jnci/djv389.

doi: 10.1093/jnci/djv390 
pmcid: pmc4862437
pmid: 26711869  [indexed medline]

